Clinical Trial: Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07802366) titled 'Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria' on Aug. 31.

Brief Summary: XPhePiccosMR is a prospective, single-arm, open label, observational study that aims to evaluate the acceptability and tolerability of XPhe Piccos, a slow-release, phenylalanine-free protein substitute in the form of tiny tablets, for use in the dietary management of phenylketonuria (PKU) in children aged three years and older.

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Phenylketonuria (PKU) and Hyperphenylalaninemia Brain Diseases, Met...